Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Payer Collaborations with Pharma: Real-world Evidence to Improve Patient Outcomes and Influence the Pipeline
Track : Track 13: Health Economics and Outcomes (HEO)/Comparative Effectiveness Research (CER)/Health Technology Assessment (HTA)
Program Code: 217
Date: Tuesday, June 25, 2013
Time: 8:00 AM to 9:30 AM  EST
Location: 151B
CHAIR :
 Christopher M. Marrone, PharmD (SCHNON), Outcomes Liaison, Eli Lilly and Company, United States
SPEAKER (S):
James Harnett, PharmD,MS (SPKNON), Senior Director, Real World Data and Analytics, Pfizer Inc, United States
 Stephen Chick, (SPKNON), Vice President, Competitive Health Insights, A Humana Company, United States
 Joseph Singer, (SPKNON), Vice President, Clinical Affairs, HealthCore Inc., a subsidiary of WellPoint Inc., United States
Description
This session will focus on the objectives and outcomes of payer/pharmaceutical real-world evidence collaborations. Speakers will include pharmaceutical representatives and payers sharing their goals, vision, and experiences of their collaborations.

Session Recording
(Code: 217)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Handout Online
(Code: 217)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Payer Collaborations with Pharma: Real-world Evidence to Improve Patient Outcomes and Influence the Pipeline